133 related articles for article (PubMed ID: 25205713)
1. Cell surface serine protease matriptase-2 suppresses fetuin-A/AHSG-mediated induction of hepcidin.
Stirnberg M; Maurer E; Arenz K; Babler A; Jahnen-Dechent W; Gütschow M
Biol Chem; 2015 Jan; 396(1):81-93. PubMed ID: 25205713
[TBL] [Abstract][Full Text] [Related]
2. Matriptase-2 suppresses hepcidin expression by cleaving multiple components of the hepcidin induction pathway.
Wahedi M; Wortham AM; Kleven MD; Zhao N; Jue S; Enns CA; Zhang AS
J Biol Chem; 2017 Nov; 292(44):18354-18371. PubMed ID: 28924039
[TBL] [Abstract][Full Text] [Related]
3. Retinal expression of the serine protease matriptase-2 (Tmprss6) and its role in retinal iron homeostasis.
Gnana-Prakasam JP; Baldowski RB; Ananth S; Martin PM; Smith SB; Ganapathy V
Mol Vis; 2014; 20():561-74. PubMed ID: 24791141
[TBL] [Abstract][Full Text] [Related]
4. Liver hemojuvelin protein levels in mice deficient in matriptase-2 (Tmprss6).
Krijt J; Fujikura Y; Ramsay AJ; Velasco G; Nečas E
Blood Cells Mol Dis; 2011 Aug; 47(2):133-7. PubMed ID: 21612955
[TBL] [Abstract][Full Text] [Related]
5. Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice.
Nai A; Rubio A; Campanella A; Gourbeyre O; Artuso I; Bordini J; Gineste A; Latour C; Besson-Fournier C; Lin HY; Coppin H; Roth MP; Camaschella C; Silvestri L; Meynard D
Blood; 2016 May; 127(19):2327-36. PubMed ID: 26755707
[TBL] [Abstract][Full Text] [Related]
6. Matriptase-2 and Hemojuvelin in Hepcidin Regulation: In Vivo Immunoblot Studies in
Krijt J; Frýdlová J; Gurieva I; Přikryl P; Báječný M; Steinbicker AU; Vokurka M; Truksa J
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800732
[TBL] [Abstract][Full Text] [Related]
7. The catalytic, stem, and transmembrane portions of matriptase-2 are required for suppressing the expression of the iron-regulatory hormone hepcidin.
Mao P; Wortham AM; Enns CA; Zhang AS
J Biol Chem; 2019 Feb; 294(6):2060-2073. PubMed ID: 30559294
[TBL] [Abstract][Full Text] [Related]
8. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin.
Silvestri L; Pagani A; Nai A; De Domenico I; Kaplan J; Camaschella C
Cell Metab; 2008 Dec; 8(6):502-11. PubMed ID: 18976966
[TBL] [Abstract][Full Text] [Related]
9. The ectodomain of matriptase-2 plays an important nonproteolytic role in suppressing hepcidin expression in mice.
Enns CA; Jue S; Zhang AS
Blood; 2020 Aug; 136(8):989-1001. PubMed ID: 32384154
[TBL] [Abstract][Full Text] [Related]
10. Matriptase-2, a regulatory protease of iron homeostasis: possible substrates, cleavage sites and inhibitors.
Stirnberg M; Gütschow M
Curr Pharm Des; 2013; 19(6):1052-61. PubMed ID: 23016685
[TBL] [Abstract][Full Text] [Related]
11. Suppression of the hepcidin-encoding gene Hamp permits iron overload in mice lacking both hemojuvelin and matriptase-2/TMPRSS6.
Truksa J; Gelbart T; Peng H; Beutler E; Beutler B; Lee P
Br J Haematol; 2009 Nov; 147(4):571-81. PubMed ID: 19751239
[TBL] [Abstract][Full Text] [Related]
12. Into the matrix: regulation of the iron regulatory hormone hepcidin by matriptase-2.
Knutson MD
Nutr Rev; 2009 May; 67(5):284-8. PubMed ID: 19386032
[TBL] [Abstract][Full Text] [Related]
13. Neogenin Facilitates the Induction of Hepcidin Expression by Hemojuvelin in the Liver.
Zhao N; Maxson JE; Zhang RH; Wahedi M; Enns CA; Zhang AS
J Biol Chem; 2016 Jun; 291(23):12322-35. PubMed ID: 27072365
[TBL] [Abstract][Full Text] [Related]
14. Matriptase-2 deficiency protects from obesity by modulating iron homeostasis.
Folgueras AR; Freitas-Rodríguez S; Ramsay AJ; Garabaya C; Rodríguez F; Velasco G; López-Otín C
Nat Commun; 2018 Apr; 9(1):1350. PubMed ID: 29636509
[TBL] [Abstract][Full Text] [Related]
15. Inactive matriptase-2 mutants found in IRIDA patients still repress hepcidin in a transfection assay despite having lost their serine protease activity.
Guillem F; Kannengiesser C; Oudin C; Lenoir A; Matak P; Donadieu J; Isidor B; Méchinaud F; Aguilar-Martinez P; Beaumont C; Vaulont S; Grandchamp B; Nicolas G
Hum Mutat; 2012 Sep; 33(9):1388-96. PubMed ID: 22581667
[TBL] [Abstract][Full Text] [Related]
16. Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis.
Ramsay AJ; Hooper JD; Folgueras AR; Velasco G; López-Otín C
Haematologica; 2009 Jun; 94(6):840-9. PubMed ID: 19377077
[TBL] [Abstract][Full Text] [Related]
17. Decreased hemojuvelin protein levels in mask mice lacking matriptase-2-dependent proteolytic activity.
Frýdlová J; Fujikura Y; Vokurka M; Nečas E; Krijt J
Physiol Res; 2013; 62(4):405-11. PubMed ID: 23590607
[TBL] [Abstract][Full Text] [Related]
18. Proteolytic processing of the serine protease matriptase-2: identification of the cleavage sites required for its autocatalytic release from the cell surface.
Stirnberg M; Maurer E; Horstmeyer A; Kolp S; Frank S; Bald T; Arenz K; Janzer A; Prager K; Wunderlich P; Walter J; Gütschow M
Biochem J; 2010 Aug; 430(1):87-95. PubMed ID: 20518742
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia.
Silvestri L; Guillem F; Pagani A; Nai A; Oudin C; Silva M; Toutain F; Kannengiesser C; Beaumont C; Camaschella C; Grandchamp B
Blood; 2009 May; 113(22):5605-8. PubMed ID: 19357398
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor activator inhibitor type 2 (HAI-2) modulates hepcidin expression by inhibiting the cell surface protease matriptase-2.
Maurer E; Gütschow M; Stirnberg M
Biochem J; 2013 Mar; 450(3):583-93. PubMed ID: 23293962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
